Soluble immune checkpoints in lung cancer: linking prognostic signatures to immunotherapy response – a meta-analysis
IntroductionNon-small cell lung cancer (NSCLC) remains one of the leading causes of cancer-related death, with most patients diagnosed at advanced, unresectable stages. Although immune-checkpoint inhibitors have transformed the therapeutic landscape, o…